Company profile: PPD
1.1 - Company Overview
Company description
- Provider of CRO services across multiple therapeutic areas, enabling accelerated innovation and drug development through patient-centered strategies and data analytics. Offerings include GMP laboratory and analytical services, Decentralized Clinical Trials, Accelerated Enrollment Solutions, Preclarus data integration tools, regulatory affairs services, and integrated clinical development consulting.
Products and services
- Accelerated Enrollment Solutions (AES): Utilizes a global-scale network of sites and patient data to streamline clinical trial recruitment and reduce timelines across therapeutic areas
- Decentralized Clinical Trials (DCT): Conducts telemedicine-enabled studies using remote monitoring to improve recruitment and retention while ensuring data quality
- GMP Laboratory Services: Delivers GMP-grade analytical services for small molecules and biologics, including testing of APIs, finished drug products, and medical devices across all phases of drug development
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PPD
Cambrian Bio
HQ: United States
Website
- Description: Provider of therapeutics to lengthen healthspan via a Distributed Development Company model, advancing programs targeting biological drivers of aging, including ATX-304 (a pan-AMPK activator for cardiometabolic diseases, Phase 1B), Tornado Therapeutics (developing mTOR inhibitors with novel selectivity profiles), and Telovance (a protein complex to enhance ex-vivo cell therapy expansion).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cambrian Bio company profile →
NeuroTrax
HQ: United States
Website
- Description: Provider of BrainCare, a cloud-based brain wellness assessment platform offering tests across seven cognitive areas, graphical reports for clinicians to track baselines and progress, and personalized activity and brain training recommendations, plus a 30-minute Post COVID Testing Suite evaluating memory, executive function, attention, and information processing speed for post-COVID cognitive assessment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NeuroTrax company profile →
Vibalogics
HQ: Germany
Website
- Description: Provider of contract development and manufacturing services for live biological products, including process development, manufacturing and fill & finish for oncolytic viruses, gene therapies and vaccines. Capabilities span viral vector and live virus production, RNA and LNP manufacturing, plasmid development and manufacturing, upstream/downstream and formulation development, and cGMP manufacturing for phase 1–2 clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vibalogics company profile →
DynaKin
HQ: Spain
Website
- Description: Provider of contract research services featuring a GLP biolab, model-based drug development, GCP clinical trial design and execution, and product-oriented R&D.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DynaKin company profile →
iCardiac
HQ: United States
Website
- Description: Provider of cardiac safety biomarkers and ECG-based markers for assessing the cardiac safety profile of drugs in development; offers Dynamic QTbtbsm, a suite of ECG-based cardiac safety markers, used in cardiac clinical trials by pharmaceutical, biotechnology, and medical device companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full iCardiac company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PPD
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PPD
2.2 - Growth funds investing in similar companies to PPD
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PPD
4.2 - Public trading comparable groups for PPD
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →